Table 2 Total WOMAC and VAS
| Total WOMAC | |||
|---|---|---|---|
| Group | Pre-operative (baseline) | Latest Follow up | p-value |
| Control (n = 16) | 52.70 ± 2.05 | 24.3 ± 2.61 | p < 0.0001 |
| Study group (n = 16) | 52.16 ± 1.88 | 23.7 ± 2.12 | p < 0.0001 |
| VAS | |||
| Group | |||
| Control (n = 16) | 8.7 ± 1.02 | 2.98 ± 2.61 | p < 0.0001 |
| Study group (n = 16) | 8.5 ± 1.22 | 3.25 ± 1.33 | p < 0.0001 |